211At-BC8-B10
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 211At-BC8-B10, covering 2025-10-16 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia [Phase 1, Phase 2]